» Articles » PMID: 7589046

Effect of Combined Atenolol and Nifedipine Administration on Psychomotor Performance in Normal Subjects

Overview
Specialty Pharmacology
Date 1995 Jan 1
PMID 7589046
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to evaluate the central effects of single doses of the beta-adrenoceptor antagonist atenolol and the calcium antagonist nifedipine retard, alone and in combination, in normal subjects. Twelve normal males received single oral doses of atenolol 100 mg, nifedipine retard 20 mg, atenolol 100 mg and nifedipine retard 20 mg in combination, diazepam 5 mg (active control), and each of two matching placebos in a double-blind, randomised fashion. Psychomotor performance was assessed using digit symbol substitution, letter cancellation (LCT), continuous attention, choice reaction time, finger tapping, immediate recall and short-term memory. Two flash fusion and critical flicker fusion thresholds were measured and subjective assessments made using visual analogue scales (VAS). Diazepam 5 mg significantly worsened LCT scores at 4h, significantly impaired alertness at 2 h and 4 h, and tended to increase reaction time and impair continuous attention and physiological measurements. Atenolol 100 mg alone significantly reduced alertness at 2 h and 4 h, and also tended to impair physiological measurements. Nifedipine retard 20 mg produced no significant psychomotor effects. Combined atenolol and nifedipine retard administration produced a small but significant improvement in continuous attention and a reduction in body sway, with no adverse effects being evident on performance or subjective awareness. The results suggest that no significant adverse effects on psychomotor performance are produced by single doses of atenolol 100 mg and nifedipine retard 20 mg when given together in normal subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The effects of fall-risk-increasing drugs on postural control: a literature review.

de Groot M, van Campen J, Moek M, Tulner L, Beijnen J, Lamoth C Drugs Aging. 2013; 30(11):901-20.

PMID: 24005984 DOI: 10.1007/s40266-013-0113-9.

References
1.
Currie D, Lewis R, McDevitt D, Nicholson A, Wright N . Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood. Br J Clin Pharmacol. 1988; 26(2):121-8. PMC: 1386519. DOI: 10.1111/j.1365-2125.1988.tb03378.x. View

2.
Aoki K, Kondo S, Mochizuki A, Yoshida T, Kato S, Kato K . Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J. 1978; 96(2):218-26. DOI: 10.1016/0002-8703(78)90089-3. View

3.
Husted S, Nielsen H, Christensen C, Lederballe Pedersen O . Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent. Eur J Clin Pharmacol. 1982; 22(2):101-3. DOI: 10.1007/BF00542452. View

4.
Kindermann W, Widmann W, Rieder T, Kullmer T . [Physical performance in antihypertensive therapy. Results of a calcium antagonist-beta blocker combination]. Fortschr Med. 1987; 105(4):75-81. View

5.
Nicholson A, Wright N, Zetlein M, Currie D, McDevitt D . Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway. Br J Clin Pharmacol. 1988; 26(2):129-41. PMC: 1386520. DOI: 10.1111/j.1365-2125.1988.tb03379.x. View